Christos Mandanis, MD
Clinical Cardiac Electrophysiology · Wichita, KSNPI 1770636854
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,406 of the $10,272 with a category attached, or 81.8%. 39 manufacturers reported payments, led by Abbott at 32.6% of the total. Reporting peaked in 2024 at $3,053 and has fallen 63.6% since, to $1,110 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KS, where the typical reported total is $20,088.
Across 328 payments — averaging $31.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$2K
- AstraZeneca$583
- Boehringer Ingelheim$466
- Johnson & Johnson$448
- Merck$401
- plus $3K from 33 others
What the payments were for
- Travel & lodging$1,83118%
- Food & beverage$8,40682%
- Education$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 63 | $3,350 |
| Medtronic(2 entities) | 27 | $2,456 |
| AstraZeneca | 37 | $583 |
| Boehringer Ingelheim | 19 | $466 |
| Johnson & Johnson | 24 | $448 |
| Merck | 27 | $401 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $294 |
| Novo Nordisk | 8 | $267 |
| Sanofi-aventis U.S. LLC | 16 | $265 |
| Amgen | 15 | $229 |
| Boston Scientific | 6 | $183 |
| E.r. Squibb & Sons, L.L.C. | 8 | $137 |
| Cvrx, Inc. | 2 | $131 |
| Biosense Webster, Inc. | 4 | $131 |
| Pfizer | 7 | $97 |
| Shockwave Medical, Inc | 3 | $81 |
| Amarin Pharma, Inc. | 5 | $80 |
| Novartis | 5 | $76 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Biotronik Inc. | 3 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 3 | $42 |
| Elutia, Inc. | 2 | $32 |
| Bardy Diagnostics, Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Amryt Pharma Holdings Ltd | 2 | $26 |
| Cardiva Medical, Inc. | 1 | $26 |
| Stryker | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Bayer | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Edwards Lifesciences | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Infobionic, Inc | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| United Therapeutics Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,361
- AVEIR$1,304
- Confirm Rx$275
- MitraClip System$146
- Durata Defibrillation ICD Lead$141
- Wegovy$125
- JARDIANCE$124
- ALLURE QUADRA$123
- XARELTO$115
- ASSURITY$113
- Barostim Neo System$111
- Cobalt$105
How this compares
$10,272 in reported general payments places this provider in the 30th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
See all clinical cardiac electrophysiology providers in Kansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 329 | $233,157 |
| MultaqDronedarone Hcl | 186 | $171,306 |
| XareltoRivaroxaban | 152 | $136,465 |
| VerquvoVericiguat | 16 | $5,452 |
| Dofetilide | 22 | $4,489 |
| Midodrine Hcl | 32 | $3,175 |
| Amiodarone Hcl | 278 | $2,860 |
| Mexiletine Hcl | 36 | $2,539 |
| Flecainide Acetate | 40 | $1,171 |
| Metoprolol Succinate | 143 | $1,044 |
| Verapamil ErVerapamil Hcl | 57 | $959 |
| Potassium Chloride | 90 | $944 |
| Verapamil SrVerapamil Hcl | 14 | $800 |
| Diltiazem 24hr ErDiltiazem Hcl | 51 | $799 |
| Bumetanide | 27 | $721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $97 | $233,157329 claims |
| Sanofi-aventis U.S. LLCMultaq | $265 | $171,306186 claims |
| Johnson & JohnsonXarelto | $448 | $136,465152 claims |
| MerckVerquvo | $401 | $5,45216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
Other clinical cardiac electrophysiology in Wichita
- Olakanmi OlagokeWichita$42K
- Amit KoduriWichita$39K
- Ghiyath Al-TabbalWichita$22K
- Dhaval ParikhWichita$11K
- P MargolisWichita$7K
- Jesus Val MejiasWichita$2K
- Ashok BajajWichita$141
- Dhanunjaya LakkireddyKansas City$1.1M
- Rakesh GopinathannairOverland Park$425K
- Rhea PimentelKansas City$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.